AI-Powered Discovery Yields WYS-694, a Broad-Spectrum Coronavirus Antiviral

AI and film animation tools lead to breakthrough in coronavirus drug discovery

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID-19 pandemic.

Researchers Develop New Broad-Spectrum Coronavirus Drug at Harvard’s Wyss Institute

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a broad-spectrum drug targeting a range of coronaviruses. Their research involved physics-driven modeling that took a page from Hollywood animation techniques.

Broad-spectrum coronavirus drug developed through AI-enabled dynamic modeling

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID-19 pandemic. Despite the development of groundbreaking technology that enables the design of prophylactic vaccines, access to those vaccines is not equal across the globe, especially in low-resource countries, and also other hesitations prevent the…

Rewrite Broad-spectrum coronavirus drug developed through AI-enabled

Open the article to view the coverage from BIOENGINEER.ORG

AI Discovers Oral Drug That Blocks Multiple Coronaviruses

Scientists have developed a new oral antiviral drug using artificial intelligence and Hollywood animation software that can block infection from multiple